AMGEN INC Annual Operating Income (Loss) in USD from 2010 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Amgen Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Amgen Inc Operating Income (Loss) for the quarter ending December 31, 2024 was $2.31B, a 81.8% increase year-over-year.
- Amgen Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was $7.26B, a 8.09% decline year-over-year.
- Amgen Inc annual Operating Income (Loss) for 2024 was $7.26B, a 8.09% decline from 2023.
- Amgen Inc annual Operating Income (Loss) for 2023 was $7.9B, a 17.4% decline from 2022.
- Amgen Inc annual Operating Income (Loss) for 2022 was $9.57B, a 25.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)